[go: up one dir, main page]

WO2012050397A3 - 생약 추출물을 포함하는 신장암 예방 또는 치료용 약학적 조성물 - Google Patents

생약 추출물을 포함하는 신장암 예방 또는 치료용 약학적 조성물 Download PDF

Info

Publication number
WO2012050397A3
WO2012050397A3 PCT/KR2011/007675 KR2011007675W WO2012050397A3 WO 2012050397 A3 WO2012050397 A3 WO 2012050397A3 KR 2011007675 W KR2011007675 W KR 2011007675W WO 2012050397 A3 WO2012050397 A3 WO 2012050397A3
Authority
WO
WIPO (PCT)
Prior art keywords
preventing
pharmaceutical composition
kidney cancer
composition including
herbal medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2011/007675
Other languages
English (en)
French (fr)
Other versions
WO2012050397A2 (ko
Inventor
황성연
안성훈
서근영
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KOREA BIO MEDICAL SCIENCE INSTITUTE
Original Assignee
KOREA BIO MEDICAL SCIENCE INSTITUTE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KOREA BIO MEDICAL SCIENCE INSTITUTE filed Critical KOREA BIO MEDICAL SCIENCE INSTITUTE
Publication of WO2012050397A2 publication Critical patent/WO2012050397A2/ko
Publication of WO2012050397A3 publication Critical patent/WO2012050397A3/ko
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815—Lycium (desert-thorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

본 발명은 당귀의 생약 추출물을 유효성분으로 포함하는 신장암 예방 또는 치료용 약학적 조성물에 관한 것으로 더욱 상세하게는 홍삼, 당귀, 오미자, 토사자 및 울금의 추출물을 유효성분으로 포함하여, 높은 항산화 활성을 가지며, 특히, 신장암에 대한 항암 효과가 탁월한 신장암 예방 또는 치료용 약학적 조성물에 관한 것이다.
PCT/KR2011/007675 2010-10-14 2011-10-14 생약 추출물을 포함하는 신장암 예방 또는 치료용 약학적 조성물 Ceased WO2012050397A2 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020100100151A KR20120038612A (ko) 2010-10-14 2010-10-14 생약 추출물을 포함하는 신장암 예방 또는 치료용 약학적 조성물
KR10-2010-0100151 2010-10-14

Publications (2)

Publication Number Publication Date
WO2012050397A2 WO2012050397A2 (ko) 2012-04-19
WO2012050397A3 true WO2012050397A3 (ko) 2012-08-30

Family

ID=45938824

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2011/007675 Ceased WO2012050397A2 (ko) 2010-10-14 2011-10-14 생약 추출물을 포함하는 신장암 예방 또는 치료용 약학적 조성물

Country Status (2)

Country Link
KR (1) KR20120038612A (ko)
WO (1) WO2012050397A2 (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014069690A1 (ko) * 2012-10-31 2014-05-08 주식회사 한국전통의학연구소 백화사설초 추출물을 포함하는 신장암 치료용 조성물 및 건강 기능성 식품
CN103063793A (zh) * 2013-01-01 2013-04-24 吉林紫鑫药业股份有限公司 锁阳补肾胶囊的含量测定方法
KR101898187B1 (ko) * 2017-05-11 2018-09-12 주식회사 비비씨 목단피, 구기자, 오미자를 원료로 한 항산화 및 항암 활성을 가진 복합추출물 제조방법
WO2019124604A1 (ko) * 2017-12-22 2019-06-27 경상대학교병원 프로안토시아니딘을 유효성분으로 함유하는 편평상피암의 예방 또는 치료용 약학 조성물
EP4265266A1 (de) * 2023-03-16 2023-10-25 Patentpool Target GmbH Kit of parts zur therapie von medulloblastomen und diffusen astrozytomen mittels alkoholischer und/oder w ssriger extrakte verschiedener cuscuta spp
CN116850221B (zh) * 2023-07-20 2024-06-11 山东省科学院菏泽分院 一种牡丹雄蕊菟丝子复合物及其制备方法和应用
CN116832105B (zh) * 2023-07-21 2024-05-14 山东惠民德赛克生物科技有限公司 一种保肾利尿的中药制剂及其制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030008080A (ko) * 2001-07-16 2003-01-24 김희숙 면역증강 활성이 우수한 생약재 조성물 및 이를 포함하는기능성 식품
KR20070005289A (ko) * 2005-07-06 2007-01-10 한국식품연구원 오미자 및/또는 산머루 추출물을 함유한 항암 치료의부작용 완화제

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030008080A (ko) * 2001-07-16 2003-01-24 김희숙 면역증강 활성이 우수한 생약재 조성물 및 이를 포함하는기능성 식품
KR20070005289A (ko) * 2005-07-06 2007-01-10 한국식품연구원 오미자 및/또는 산머루 추출물을 함유한 항암 치료의부작용 완화제

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ANAND, P. ET AL.: "Curcumin and cancer: An ''old-age'' disease with an ''age-old'' solution.", CANCER LETTERS, vol. 267, 2008, pages 133 - 164 *
HAN, E.J. ET AL.: "Effects of Quinone Reductase Induction and Cytotoxicity of the Angelica radix Extracts.", JOURNAL OF THE KOREAN SOCIETY OF FOOD SCIENCE AND NUTRITION, vol. 29, no. 1, 2000, pages 147 - 152 *
KIM, C.H. ET AL.: "Growth Inhibition of Red Ginseng Extracts Against Human Tumor Cell Line by Clonogenic Assay.", JOURNAL OF GINSENG RESEARCH, vol. 22, no. 3, 1998, pages 188 - 192 *
VOLATE, S.R. ET AL.: "Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin).", CARCINOGENESIS, vol. 26, no. 8, 2005, pages 1450 - 1456 *

Also Published As

Publication number Publication date
KR20120038612A (ko) 2012-04-24
WO2012050397A2 (ko) 2012-04-19

Similar Documents

Publication Publication Date Title
WO2012050396A3 (ko) 생약 추출물을 포함하는 간암 예방 또는 치료용 약학적 조성물
WO2012050398A3 (ko) 생약 추출물을 포함하는 폐암 예방 또는 치료용 약학적 조성물
WO2012050397A3 (ko) 생약 추출물을 포함하는 신장암 예방 또는 치료용 약학적 조성물
CO7170145A2 (es) Complejos de polielectrolitos para mejoramiento de un biocida
WO2013158814A8 (en) Immediate release, abuse deterrent pharmaceutical compositions
WO2012024620A3 (en) Autotaxin inhibitors and uses thereof
EP3067059A4 (en) Pharmaceutical composition for preventing or treating thyroid diseases, containing lonicera caerulea l. var. edulis fruit extract as active ingredient
WO2008007244A3 (en) Composition for improving eye health
WO2011059292A3 (ko) 피부세포증식 촉진, 항산화 및 항알러지 효과가 우수한 알로에 베라 새순 농축물 또는 추출물
WO2012091440A3 (en) Composition for improvement, treatment and prevention of gastrointestinal motility disorders
EP3034082A4 (en) Pharmaceutical composition for treating or preventing neuropsychitric disease, containing flavone-6-c-glucose derivatives as active ingredients
MY172040A (en) Synergistic dietary supplement for enhancing physical performance
WO2015058664A8 (zh) 淫羊藿苷元在制备预防或治疗血细胞减少药物中的用途
EP3279210A4 (en) Peptide having anticancer activity, and pharmaceutical composition and dietary supplement composition for preventing and treating cancer, both of which contain same as active ingredient
WO2012162439A3 (en) Compositions comprising fusidic acid and packages therefor
WO2011043631A3 (ko) 호장근 추출물, 이의 분획물 또는 스틸벤계 화합물을 포함하는 감기의 예방 및 치료용 약학 조성물
EP4233896A3 (en) Method for preparing an immunogenic lysate, the lysate obtained, dendritic cells loaded with such lysate and a pharmaceutical composition comprising the lysate or the dendritic cells
WO2010058982A3 (en) Antioxidant cosmetic composition containing extract of processed peony, polygonati rhizoma or lily
HK1249410A1 (zh) Ox40抗体和tlr4调节子的组合及其用途
WO2013080205A8 (en) Jojoba extract useful in improving skin barrier functions
WO2012024399A3 (en) Compositions comprising paulownin and/or paulownia extracts and uses thereof
WO2013170086A3 (en) Formulations for the delivery of active ingredients
EP3352750A4 (en) Cyclohexene derivative, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic disease comprising the same as active ingredient
WO2012040082A3 (en) Antidiabetic solid pharmaceutical compositions
WO2013100718A3 (ko) 라저스트로에미아 오바리폴리아 추출물 또는 이의 분획물을 유효성분으로 포함하는 염증성 질환 또는 천식의 예방 또는 치료용 약학적 조성물

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11832784

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11832784

Country of ref document: EP

Kind code of ref document: A2